Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COCTAIL II: Abciximab Delivery Methods in STEMI
NCT01499407Phase 4Unknown
- Sponsor
- CLI Foundation
- Start
- Dec 2011
- Primary completion
- Dec 2012
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of abciximab in ST elevation myocardial infarction (STEMI), sponsored by CLI Foundation. Status: unknown.
02
Drugs
abciximab
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01499407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01499407.